Home  |  Contact

Cellosaurus YST-1 (CVCL_5192)

[Text version]

Cell line name YST-1
Accession CVCL_5192
Resource Identification Initiative To cite this cell line use: YST-1 (RRID:CVCL_5192)
Comments Doubling time: ~40 hours (PubMed=1980563).
Disease Schwannoma (NCIt: C3269)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 8Y
Category Cancer cell line
STR profile Source(s): PubMed=28556483; RCB; TKG

Markers:
AmelogeninX
CSF1PO12
D2S133818,19
D3S135816,18
D5S81810,11
D7S8209,10
D8S117910,15
D13S3178,12
D16S53910,12
D18S5113
D19S43313,14
D21S1129,31
FGA19,24
TH017,9
TPOX8,11
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=1980563; DOI=10.1007/BF02899420
Nagashima Y., Ohaki Y., Tanaka Y., Sumino K., Funabiki T., Okuyama T., Watanabe S.-I., Umeda M., Misugi K.
Establishment of an epithelioid malignant schwannoma cell line (YST-1).
Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol. 59:321-327(1990)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=16510576; DOI=10.1158/0008-5472.CAN-05-3330
Miller S.J., Rangwala F., Williams J., Ackerman P., Kong S., Jegga A.G., Kaiser S., Aronow B.J., Frahm S., Kluwe L., Mautner V.-F., Upadhyaya M., Muir D., Wallace M., Hagen J., Quelle D.E., Watson M.A., Perry A., Gutmann D.H., Ratner N.
Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
Cancer Res. 66:2584-2591(2006)

PubMed=28556483; DOI=10.1002/1878-0261.12086
Kolberg M., Bruun J., Murumagi A., Mpindi J.P., Bergsland C.H., Holand M., Eilertsen I.A., Danielsen S.A., Kallioniemi O., Lothe R.A.
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Mol. Oncol. 11:1156-1171(2017)

Cross-references
Cell line collections RCB; RCB2136
TKG; TKG 0454
Ontologies CLO; CLO_0050136
Biological sample resources BioSample; SAMN03472012
Other Wikidata; Q54995528
Entry history
Entry creation04-Apr-2012
Last entry updated05-Jul-2019
Version number13